ASSET PURCHASE AGREEMENTAsset Purchase Agreement • March 11th, 2016 • Galena Biopharma, Inc. • Pharmaceutical preparations • Delaware
Contract Type FiledMarch 11th, 2016 Company Industry JurisdictionTHIS ASSET PURCHASE AGREEMENT (this “Agreement”), dated as of December 17, 2015, is made by and between GALENA BIOPHARMA, INC., a Delaware corporation (“Seller”), and MIDATECH PHARMA PLC, a public limited company organized under the laws of England and Wales with registered number 09216368 (“Purchaser”). Seller and Purchaser are sometimes individually referred to herein as a “Party” and are sometimes collectively referred to herein as the “Parties”. Capitalized terms not otherwise defined in the text of this Agreement shall have the meanings set forth in Article I of this Agreement.
ASSET PURCHASE AGREEMENTAsset Purchase Agreement • March 10th, 2016 • Galena Biopharma, Inc. • Pharmaceutical preparations • Delaware
Contract Type FiledMarch 10th, 2016 Company Industry JurisdictionTHIS ASSET PURCHASE AGREEMENT (this “Agreement”), dated as of December 17, 2015, is made by and between GALENA BIOPHARMA, INC., a Delaware corporation (“Seller”), and MIDATECH PHARMA PLC, a public limited company organized under the laws of England and Wales with registered number 09216368 (“Purchaser”). Seller and Purchaser are sometimes individually referred to herein as a “Party” and are sometimes collectively referred to herein as the “Parties”. Capitalized terms not otherwise defined in the text of this Agreement shall have the meanings set forth in Article I of this Agreement.